Skip to main content

Closed

NBTX: Nanobiotix S.A. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-132.1% / yr

Operating margin-36.5%

ROIC-74.3%

Financially safe

Stretched

Debt / equity-1.13×

Interest coverage-1.0×

Current ratio1.09×

Nanobiotix S.A.

NBTXNASDAQ Global Select·USD·Closed

Nanobiotix S.A.

NBTXNASDAQ·USD·Closed

$38.38

−4.42%

$38.38

−$1.77 (4.42%)

52W Range

63thpctl

Volume

1.33×avg

Mkt Cap

1.94BUSD

P/E

-66.1TTM

Div Yield

–ann

52W Range

63thpctl

Volume

1.33×avg

Market Cap

1.94BUSD

P/E Ratio

-66.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings